Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence

NCT04704050 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Sponsor withdrew funding

Conditions

Atrial Fibrillation
Atrial Fibrillation Recurrent

Interventions

DRUG: dronedarone 400 mg Oral Tablet
DRUG: Placebo

Sponsor

Tulane University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]